Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 3

Evaluation of the effects of dexmedetomidine and midazolam on plasma and cerebrospinal fluid beta-endorphin levels in rats

Pages
737–740
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Different findings from both this study and in vitro and human studies; the number of subjects, the use of different drug doses, the differences in measurement times, the absence of control groups may be due to methodological differences, and more research is needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endorphins are endogenous peptides that play a role in the regulation of pain, behavior, neuroendocrine and autonomic functions.
📊
Key Findings & Data:In this experimental study, 36 rats were divided into 6 groups.
💡
Conclusion & Impact:Different findings from both this study and in vitro and human studies; the number of subjects, the use of different drug doses, the differences in measurement times, the absence of control groups may be due to methodological differences, and more research is needed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Endorphins are endogenous peptides that play a role in the regulation of pain, behavior, neuroendocrine and autonomic functions. In our study, we aimed to investigate the role of β endorphins in these effects of midazolam and dexmedetomidine. In this experimental study, 36 rats were divided into 6 groups. Group 1: (control) (n=6): An average of 100-150μl CSF samples were obtained after general anesthesia was achieved. An intracardiac 3-4ml blood sample was then taken. Group 2: (sham) (n=6): intraperitoneal 1 mL saline was administered. For all other groups after general anesthesia; Group 3: (midazolam-1) (n=6): intraperitoneal 4mg/kg midazolam was administered. Group 4: (midazolam-2) (n=6): 12mg/kg midazolam was administered intraperitoneally. Group 5: (Dexmedetomidine-1) (n=6): Dexmedetomidine 50μg/kg was administered intraperitoneally. Group 6: (Dexmedetomidine-2) (n=6): Dexmedetomidine 150 μg/kg was administered intraperitoneally.CSF and plasma samples were taken with the same method. All samples were stored at -80 °C. No statistically significant difference was found between the levels of rat CSF β-endorphin. However, when the plasma ß-endorphin levels of rats were evaluated, there was a statistically significant difference between the groups. No difference was found between the levels of plasma ß-endorphin in the patients who received midazolam, while plasma ß-endorphin levels of 50 μg/kg with dexmedetomidine were found to be lower than the control group. However, the values of the 150 μg/kg dexmedetomidine group did not support this result. Different findings from both this study and in vitro and human studies; the number of subjects, the use of different drug doses, the differences in measurement times, the absence of control groups may be due to methodological differences, and more research is needed.

🔖

Cite This Article

Kucuk, C., Kadiogullari, N. (2022). Evaluation of the effects of dexmedetomidine and midazolam on plasma and cerebrospinal fluid beta-endorphin levels in rats. Medicine Science, Cilt: 10 - Sayı: 3, 737–740. https://ajindex.com/articles/572126

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Oyama T, Jin T, Yamaya R et al. Profound analgesic effects of betaendorphin in man. Lancet. 1980;1:122-4.
  2. Serrao JM, Stubbs SC, Goodchild CS et al. Intrathecal midazolam and fentanyl in the rat: evidence for different spinal antinociceptive effects. Anesthesiology. 1989;70:780-6.
  3. Niv D, Davidovich S, Geller E et al. Analgesic and hyperalgesic effects of midazolam: dependence on route of administration. Anesth Analg. 1988;67:1169-73.
  4. Kalso EA, Poyhia R, Rosenberg PH. Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist. Pharmacol Toxicol. 1991;68:140-3.
  5. De Wied D, Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol Rev. 1982;62:976-1059.
  6. Yaksh TL, Gross KE, Li CH. Studies on the intrathecal effect of betaendorphin in primate. Brain Res. 1982;10;241:261-9. Jensen TS. Endogenous antinociceptive systems: studies on spinal and supraspinal modulating mechanisms with particular reference to monoaminergic and opioid systems. Acta Neurol Scand Suppl. 1986;108:1- 35. Porreca F, Burks TF. Supraspinal opioid receptors in antinociception. In: A. Herz (eds.), Handbook of experimental pharmacology, Vol. 104/II, Opioids, Springer-Verlag, Berlin, 1993;21-51 Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed., Philadelphia: W.B. Saunders Company, 1992.
  7. Jeffcoate WJ, Rees LH, McLoughlin L et al. beta-Endorphin in human cerebrospinal fluid. Lancet. 1978;15;2:119-21.
  8. Bach FW, Schmidt JF, Faber T. Radioimmunoassay of beta-endorphin in ventricular and lumbar cerebrospinal fluid. Clin Chem. 1992;38:847-52.
  9. Laatikainen TJ, Salminen KR, Sulkava RO, et al. Determination of betaendorphin and beta-lipotropin in human cerebrospinal fluid. Clin Chim Acta. 1985;15;145:325-9.
  10. Smith R, Owens PC, Lovelock M, et al. Acute hemorrhagic stress in conscious sheep elevates immunoreactive beta-endorphin in plasma but not in cerebrospinal fluid. Endocrinology. 1986;118:2572-6.
  11. Ramirez-Gonzalez MD, Barna I, Wiegant VM, et al. Effect of anaesthetics on the release of beta-endorphin-immunoreactivity in rat plasma. Life Sci. 1991;48:1371-7.
  12. Yamamoto T, Sako N, Maeda S. Effects of taste stimulation on betaendorphin levels in rat cerebrospinal fluid and plasma. Physiol Behav. 2000;69:345-50.
  13. Ozkose Z, Mentes BB, Gorgul A. In: Anesthesia in experimental animals. 1998;122. Aantaa R, Jaakola ML, Kallio A, et al. A comparison of dexmedetomidine, and alpha 2-adrenoceptor agonist, and midaz